Compound ID | 2738
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the A-site of large ribosome unit preventing peptide bond formation |
| Description: | Natural product from Streptomyces sparsogenes; shows selective antitumor activity |
| Year first mentioned: | 1962 |
| Development status: | Inactive |
| Reason dropped: | Strong retinotoxicity during Phase 1 clinical trial as anticancer drug |